Table 1 Patient and tumor characteristics (n = 25 patients)
Characteristic | Value | |
|---|---|---|
Initial treatment | ||
RP | 10 | 40% |
RP + salvage RT | 15 | 60% |
Pre-operative PSA (μg/l)a | ||
median (IQR) | 9.1 | (5.4–20.4) |
mean (range) | 12.7 | (1.8–40.5) |
Gleason score | ||
6 | 1 | 4% |
7 | 13 | 52% |
8 | 7 | 28% |
9 | 4 | 16% |
T stage | ||
pT2 | 11 | 44% |
pT3 | 14 | 56% |
ECE | ||
no | 13 | 52% |
yes | 12 | 48% |
SVI | ||
no | 19 | 76% |
yes | 6 | 24% |
SM | ||
negative | 13 | 52% |
positive | 12 | 48% |